Thomas Bogle is a Director in the Health Industries Advisory practice of PricewaterhouseCoopers Advisory Services LLC with a focus on Pricing, Contracting and Gross to Net and is recognized as a subject matter expert focused in the area of Pricing & Contract Strategy and Operations, Gross-to-Net, and Government Price Reporting. Thomas’ main client focus includes, both branded and generic pharmaceutical manufacturers, biotech and medical device companies. Additionally, he has worked with both Healthcare Providers and Distributors to identify key risks as it relates to their regulatory requirements. He has provided clients with advice and managed engagements in relation to business process improvement, large-scale technology implementations and enhancements, and strategy development. Throughout his career, Thomas has had significant experience across a number of different types of client engagements, including overseeing and completing diagnostics and current state assessments, future state technology and operations roadmap development, gap analyses related to policies, procedures and systems integrations, systems reviews and implementations (including Contract Lifecycle Management, Gross-to-Net, Revenue Management, and Government Price Reporting), merger integration, Department of Justice investigations and inquiries, and forensic accounting investigations. Thomas has also had experience in assisting clients and providing advice as it relates to compliance monitoring and risk mitigation strategies. Specialties: Market Access, Contract Operations, Contract Lifecycle Management, Gross-to-Net, Managed Markets, Technology Implementations, Data & Analytics, Investigations, Litigation Support, Damage Models, Business Analytics, Risk Assessments, Compliance, Government Price Reporting